India

Resource March 12, 2015

Flexibility of Oral Cholera Vaccine Dosing—A Randomized Controlled Trial Measuring Immune Responses Following Alternative Vaccination Schedules in a Cholera Hyper-Endemic Zone

Article published by PLOS Neglected Tropical Diseases on 12-March-2015 by Kanungo S. et al.

Read more about Flexibility of Oral Cholera Vaccine Dosing—A Randomized Controlled Trial Measuring Immune Responses Following Alternative Vaccination Schedules in a Cholera Hyper-Endemic Zone

Resource July 1, 2014

Safety and Immunogenicity of a Live Oral Recombinant Cholera Vaccine VA1.4: A Randomized, Placebo Controlled Trial in Healthy Adults in a Cholera Endemic Area in Kolkata, India

Article published by PLOS One on 1-July-2014 by Kanungo S. et al.

Read more about Safety and Immunogenicity of a Live Oral Recombinant Cholera Vaccine VA1.4: A Randomized, Placebo Controlled Trial in Healthy Adults in a Cholera Endemic Area in Kolkata, India

Resource February 6, 2014

Mass Vaccination with a New, Less Expensive Oral Cholera Vaccine Using Public Health Infrastructure in India: The Odisha Model

Article published by PLOS Neglected Tropical Diseases on 06-February-2014 by Kar SK. et al.

Read more about Mass Vaccination with a New, Less Expensive Oral Cholera Vaccine Using Public Health Infrastructure in India: The Odisha Model

Resource October 17, 2013

5 Year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: A cluster-randomised, double-blind, placebo-controlled trial

Article published in The Lancet on 17-Oct-2013 by Bhattacharya, S. K. et al.

BACKGROUND:

Efficacy and safety of a two-dose regimen of bivalent killed whole-cell oral cholera vaccine (Shantha Biotechnics, Hyderabad, India) to 3 years is established, but long-term efficacy is not. We aimed to assess protective efficacy up to 5 years in a slum area of Kolkata, India.

Read more about 5 Year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: A cluster-randomised, double-blind, placebo-controlled trial

Resource August 13, 2013

Risk map of cholera infection for vaccine deployment: The eastern Kolkata case

Article published in PLoS One on 13-Aug-2013 by You, Y. A. et al.

Read more about Risk map of cholera infection for vaccine deployment: The eastern Kolkata case

Resource April 1, 2013

Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India

Article published in Clinical Infectious Diseases on 01-Apr-2013 by Ali, M. et al.

BACKGROUND:

We evaluated the herd protection conferred by an oral cholera vaccine using 2 approaches: cluster design and geographic information system (GIS) design.

Read more about Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India

Translate:

Flexibility of Oral Cholera Vaccine Dosing—A Randomized Controlled Trial Measuring Immune Responses Following Alternative Vaccination Schedules in a Cholera Hyper-Endemic Zone

Safety and Immunogenicity of a Live Oral Recombinant Cholera Vaccine VA1.4: A Randomized, Placebo Controlled Trial in Healthy Adults in a Cholera Endemic Area in Kolkata, India

Mass Vaccination with a New, Less Expensive Oral Cholera Vaccine Using Public Health Infrastructure in India: The Odisha Model

5 Year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: A cluster-randomised, double-blind, placebo-controlled trial

BACKGROUND:

Risk map of cholera infection for vaccine deployment: The eastern Kolkata case

Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India

BACKGROUND:

Posts by Topic

Posts by Month

Blog Contributors

David A. Sack, MD

Mohammad Ali, PhD

Jacqueline Deen, MD

Anna Lena Lopez, MD

Denise DeRoeck

Alfred Pach, PhD

Lorenz von Seidlein, MD

Anuj Bhattachan, MD

Amanda K. Debes, PhD, MS

Anne Ballard, MPH

Francisco Luquero, MD, PhD

Ella Glass, RN

Tom Davis, MPH

Abdinasir Abubakar

Stephanie Desmon

Brittany Goetsch, MA, MPH

John Mwaba, BSc, PgD, MSc

Francis Ongole

Waqo Gufu Boru, BSc., MSc (Epidemiology and Lab Management), Fellow DFIP, Fellow Lab Systems CDC/ASM

Search form

Translate:

India

Flexibility of Oral Cholera Vaccine Dosing—A Randomized Controlled Trial Measuring Immune Responses Following Alternative Vaccination Schedules in a Cholera Hyper-Endemic Zone

Safety and Immunogenicity of a Live Oral Recombinant Cholera Vaccine VA1.4: A Randomized, Placebo Controlled Trial in Healthy Adults in a Cholera Endemic Area in Kolkata, India

Mass Vaccination with a New, Less Expensive Oral Cholera Vaccine Using Public Health Infrastructure in India: The Odisha Model

5 Year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: A cluster-randomised, double-blind, placebo-controlled trial

BACKGROUND:

Risk map of cholera infection for vaccine deployment: The eastern Kolkata case

Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India

BACKGROUND:

Posts by Topic

Posts by Month

Blog Contributors

David A. Sack, MD

Mohammad Ali, PhD

Jacqueline Deen, MD

Anna Lena Lopez, MD

Denise DeRoeck

Alfred Pach, PhD

Lorenz von Seidlein, MD

Anuj Bhattachan, MD

Amanda K. Debes, PhD, MS

Anne Ballard, MPH

Francisco Luquero, MD, PhD

Ella Glass, RN

Tom Davis, MPH

Abdinasir Abubakar

Stephanie Desmon

Brittany Goetsch, MA, MPH

John Mwaba, BSc, PgD, MSc

Francis Ongole

Waqo Gufu Boru, BSc., MSc (Epidemiology and Lab Management), Fellow DFIP, Fellow Lab Systems CDC/ASM